NEW YORK ( TheStreet) -- Chindex International (Nasdaq: CHDX) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Chindex International, Inc. engages in the provision of healthcare services; and sale of medical equipment, instrumentation, and products. The company operates in two segments, Healthcare Services and Medical Products. The company has a P/E ratio of 30.8, below the average wholesale industry P/E ratio of 33.1 and above the S&P 500 P/E ratio of 21.9. Chindex International has a market cap of $266.7 million and is part of the services sector and wholesale industry. Shares are up 4.4% year to date as of the close of trading on Tuesday. You can view the full Chindex International Ratings Report or get investment ideas from our investment research center.
More from Markets
Stocks End Higher on Solid Earnings From JPMorgan Chase, UnitedHealth and J&J
Stocks finish near record highs Tuesday as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson override investors' lingering questions about the fate of U.S.-China trade talks.
Sectors to Keep an Eye on as Earnings Season Heats Up
Here are two and a half sectors to pay attention to during the earnings season. Hint: one has heavy exposure to China.